Exact Mass: 412.0092

pyraflufen

C15H13Cl2F3N2O4 (412.0204)

CONFIDENCE standard compound; INTERNAL_ID 404; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9709; ORIGINAL_PRECURSOR_SCAN_NO 9708 CONFIDENCE standard compound; INTERNAL_ID 404; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9657; ORIGINAL_PRECURSOR_SCAN_NO 9655 CONFIDENCE standard compound; INTERNAL_ID 404; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9632; ORIGINAL_PRECURSOR_SCAN_NO 9630 CONFIDENCE standard compound; INTERNAL_ID 404; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9674; ORIGINAL_PRECURSOR_SCAN_NO 9672 CONFIDENCE standard compound; INTERNAL_ID 404; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9681; ORIGINAL_PRECURSOR_SCAN_NO 9679 CONFIDENCE standard compound; INTERNAL_ID 404; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9708; ORIGINAL_PRECURSOR_SCAN_NO 9706

Imazosulfuron

C14H13ClN6O5S (412.0357)

Precursor ion, [M-H]-, is a 37Cl-isotopolog ion.; The sample was injected by direct infusion.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan. The sample was injected by direct infusion.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan.

dIDP

C10H14N4O10P2 (412.0185)

dIDP (deoxyinoside diphosphate) is a nucleoside. Deoxyinosine diphosphate appears in the urine of patients with purine metabolism abnormalities in purine nucleoside phosphorylase deficiency(OMIM 164050) [HMDB] dIDP (deoxyinoside diphosphate) is a nucleoside. Deoxyinosine diphosphate appears in the urine of patients with purine metabolism abnormalities in purine nucleoside phosphorylase deficiency(OMIM 164050).

Obtusol

C15H23Br2ClO (411.9804)

1-(5-O-phosphono-beta-D-ribofuranosyl)-3,5-bis(sulfanylcarbonyl)pyridin-1-ium

C12H15NO9PS2+ (411.9926)

Thiamphenicol glycinate

C14H18Cl2N2O6S (412.0263)

Opicapone

C15H10Cl2N4O6 (411.9977)

D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D065098 - Catechol O-Methyltransferase Inhibitors N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent

Turgorin

C13H16O13S (412.0312)

Laucapyranoid A

C15H23Br2ClO (411.9804)

Cartilagineol

C15H23Br2ClO (411.9804)

Perforenol

C15H23Br2ClO (411.9804)

2,10-Dibromo-3-chloro-7(14)-chamigren-8-ol

C15H23Br2ClO (411.9804)

4,10-Dibromo-3-choloro-7,8-epoxychamigrane

C15H23Br2ClO (411.9804)

NSC611361

C15H23Br2ClO (411.9804)

9-Hydroxy-4,10-dibromo-3-chloro-alpha-chamigrene

C15H23Br2ClO (411.9804)

Quercetagetin 3-methyl ether 7-O-sulfate

C16H12O11S (412.01)

Patuletin 7-O-sulfate

C16H12O11S (412.01)

ZINC2147628

C17H16O8S2 (412.0287)

Maybridge4_002233

C16H13ClN2O3S3 (411.9777)

LEOIDIN

C18H14Cl2O7 (412.0117)

GANGALEOIDIN

C18H14Cl2O7 (412.0117)

Patuletin 3-O-sulfate

C16H12O11S (412.01)

spiroxin A

C20H9ClO8 (411.9986)

14,14-dibromo-6,7-dihydroxytetradeca-4,13-dienoic acid|xestospongiene R

C14H22Br2O4 (411.9885)

C20H12O10

C20H12O10 (412.043)

LEOIDIN

C18H14Cl2O7 (412.0117)

Pyrafluefen-ethyl

C15H13Cl2F3N2O4 (412.0204)

Leoidin_major

C18H14Cl2O7 (412.0117)

dichloropalladium,triethylphosphane

C12H30Cl2P2Pd (412.0234)

1h,1h,9h,9h-perfluoro-1,9-nonanediol

C9H6F14O2 (412.0144)

1H,1H,1H-PENTADECAFLUORO-2-NONANONE

C9H3F15O (411.9944)

Methyl 5-iodo-2-(2-(methoxycarbonyl)phenoxy)benzoate

C16H13IO5 (411.9808)

Benzenesulfonamide,N-(3-bromopropyl)-4-methyl-N-(4-nitrophenyl)-

C16H17BrN2O4S (412.0092)

diisopropylbis(trifluoromethanesulfonyl)silane

C8H14F6O6S2Si (411.9905)

Triphenylsulfonium trifluoromethanesulfonate

C19H15F3O3S2 (412.0415)

Ethyl viologen diperchlorate

C14H18Cl2N2O8 (412.044)

thallium(i) hexafluoroacetylacetonate

C5HF6O2Tl (411.9625)

thiamphenicol

C14H18Cl2N2O6S (412.0263)

Perfluoro-3,6,9-trioxadecanoic acid

C7HF13O5 (411.9616)

ethyl 6-broMo-1,5-diMethyl-2-(2-nitroethyl)-1H-indole-3-carboxylate coMpound with Methanedione (1:1)

C16H17BrN2O6 (412.027)

2-[[4-[3-(4,5-dichloro-2-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl]phenyl]sulphonyl]ethanol

C18H18Cl2N2O3S (412.0415)

[4,4,5,5,6,7,7,7-octafluoro-2-hydroxy-6-(trifluoromethyl)heptyl] 2-methylprop-2-enoate

C12H11F11O3 (412.0533)

Brivudine monophosphate

C11H14BrN2O8P (411.9671)

Oregon green 488 carboxylate

C21H10F2O7 (412.0395)

2-(2,2-Dichloroacetamido)-3-hydroxy-3-[4-(methanesulfonyl)phenyl]propyl glycinate

C14H18Cl2N2O6S (412.0263)

Trifludimoxazin

C16H11F3N4O4S (412.0453)

Sulbenicillin(2-)

C16H16N2O7S2-2 (412.0399)

(7R)-7-(5-carboxy-5-oxopentanamido)cephalosporanate(2-)

C16H16N2O9S-2 (412.0576)

3,5-dihydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(sulfooxymethyl)oxan-2-yl]oxybenzoic acid

C13H16O13S (412.0312)

(3S,4R,6R,9R,10R)-4,9-Dibromo-10-chloro-5,5,9-trimethyl-1-methylidenespiro[5.5]undecan-3-ol

C15H23Br2ClO (411.9804)

Temocillin(2-)

C16H16N2O7S2-2 (412.0399)

[2-Hydroxy-5-(3,5,7-trihydroxy-6-methoxy-4-oxochromen-2-yl)phenyl] hydrogen sulate

C16H12O11S (412.01)

(3S,4R,5S)-4-(tert-Butyldimethylsilyloxy)-1,1-dibromo-3,5-dimethyl-1-heptene

C15H30Br2OSi (412.0433)

2-Deoxyinosine-5-diphosphate

C10H14N4O10P2 (412.0185)

A deoxyinosine phosphate compound having a diphosphate group at the 5-position.

Opicapone

C15H10Cl2N4O6 (411.9977)

D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D065098 - Catechol O-Methyltransferase Inhibitors N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent

(7R)-7-(5-carboxy-5-oxopentanamido)cephalosporanate(2-)

C16H16N2O9S (412.0576)

Dicarboxylate anion of (7R)-7-(5-carboxy-5-oxopentanamido)cephalosporanate acid.

Sulbenicillin(2-)

C16H16N2O7S2 (412.0399)

Temocillin(2-)

C16H16N2O7S2 (412.0399)

(3s)-3-bromo-5-[(1s,3s,4s)-3-bromo-4-chloro-4-methylcyclohexyl]-2,2,6-trimethyl-3,4-dihydropyran

C15H23Br2ClO (411.9804)

4,8-dibromo-9-chloro-1,5,5,9-tetramethylspiro[5.5]undec-1-en-3-ol

C15H23Br2ClO (411.9804)

(3s,4s,6r,9s)-4,9-dibromo-8-chloro-1,5,5,9-tetramethylspiro[5.5]undec-1-en-3-ol

C15H23Br2ClO (411.9804)

(2r,4r,6s,8s,9s)-4,8-dibromo-9-chloro-5,5,9-trimethyl-1-methylidenespiro[5.5]undecan-2-ol

C15H23Br2ClO (411.9804)

(2r,3s,6r,8s,9s)-2,8-dibromo-9-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecan-3-ol

C15H23Br2ClO (411.9804)

(3r,4r,4ar,6s,7s)-3,6-dibromo-7-chloro-1,4,4a,7-tetramethyl-3,4,5,6,8,9-hexahydro-2h-benzo[7]annulen-2-ol

C15H23Br2ClO (411.9804)

(4z,6s,7r)-14,14-dibromo-6,7-dihydroxytetradeca-4,13-dienoic acid

C14H22Br2O4 (411.9885)

(3r)-3-bromo-5-[(1s,3s,4s)-3-bromo-4-chloro-4-methylcyclohexyl]-2,2,6-trimethyl-3,4-dihydropyran

C15H23Br2ClO (411.9804)

(4z,6r,7r)-14,14-dibromo-6,7-dihydroxytetradeca-4,13-dienoic acid

C14H22Br2O4 (411.9885)

(2s,3s,6s,8s,9s)-2,8-dibromo-9-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecan-3-ol

C15H23Br2ClO (411.9804)

(3s,4s,6s)-4,8-dibromo-9-chloro-1,5,5,9-tetramethylspiro[5.5]undec-1-en-3-ol

C15H23Br2ClO (411.9804)

(2s,3r,6s)-2,9-dibromo-8-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecan-3-ol

C15H23Br2ClO (411.9804)

methyl 2-{7,8-dihydroxy-1,5-dioxofuro[3,4-c]isochromen-3-ylidene}-2-(3,4-dihydroxyphenyl)acetate

C20H12O10 (412.043)

3,5-dihydroxy-4-({3,4,5-trihydroxy-6-[(sulfooxy)methyl]oxan-2-yl}oxy)benzoic acid

C13H16O13S (412.0312)

(2r,3s,6r,8r,9s)-2,9-dibromo-8-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecan-3-ol

C15H23Br2ClO (411.9804)

[hydroxy([(2r,3s,5r)-3-hydroxy-5-(6-hydroxypurin-9-yl)oxolan-2-yl]methoxy)phosphoryl]oxyphosphonic acid

C10H14N4O10P2 (412.0185)

(1s,2r,3's,4s,4's,6r)-3',4-dibromo-4'-chloro-1,3,3,4'-tetramethyl-7-oxaspiro[bicyclo[4.1.0]heptane-2,1'-cyclohexane]

C15H23Br2ClO (411.9804)

(2s,3r,6s,8s,9s)-2,9-dibromo-8-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecan-3-ol

C15H23Br2ClO (411.9804)

(2s,3r,6s,8r,9r)-2,9-dibromo-8-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecan-3-ol

C15H23Br2ClO (411.9804)

2,9-dibromo-8-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecan-3-ol

C15H23Br2ClO (411.9804)

methyl 2-[(3e)-7,8-dihydroxy-1,5-dioxofuro[3,4-c]isochromen-3-ylidene]-2-(3,4-dihydroxyphenyl)acetate

C20H12O10 (412.043)

(2r,3s,6s,8r,9r)-2,9-dibromo-8-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecan-3-ol

C15H23Br2ClO (411.9804)

2,8-dibromo-9-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecan-3-ol

C15H23Br2ClO (411.9804)

(3s,6s)-4,8-dibromo-9-chloro-1,5,5,9-tetramethylspiro[5.5]undec-1-en-3-ol

C15H23Br2ClO (411.9804)

(2r,3s,6r,8s,9s)-2,9-dibromo-8-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecan-3-ol

C15H23Br2ClO (411.9804)

(1s,2r,4r,6r)-4,5'-dibromo-4'-chloro-1,3,3,4'-tetramethyl-7-oxaspiro[bicyclo[4.1.0]heptane-2,1'-cyclohexane]

C15H23Br2ClO (411.9804)

(2s,3r,6s,9s)-2,9-dibromo-8-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecan-3-ol

C15H23Br2ClO (411.9804)

14,14-dibromo-6,7-dihydroxytetradeca-4,13-dienoic acid

C14H22Br2O4 (411.9885)

(3r)-3-bromo-5-[(1r,3s,4s)-3-bromo-4-chloro-4-methylcyclohexyl]-2,2,6-trimethyl-3,4-dihydropyran

C15H23Br2ClO (411.9804)

(3r,4s,6s,8s,9s)-4,8-dibromo-9-chloro-1,5,5,9-tetramethylspiro[5.5]undec-1-en-3-ol

C15H23Br2ClO (411.9804)

(2r,4r,6r,8r,9s)-4,8-dibromo-9-chloro-5,5,9-trimethyl-1-methylidenespiro[5.5]undecan-2-ol

C15H23Br2ClO (411.9804)

3,5-dihydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[(sulfooxy)methyl]oxan-2-yl]oxy}benzoic acid

C13H16O13S (412.0312)

(1r,2r,3's,4r,4's,6s)-3',4-dibromo-4'-chloro-1,3,3,4'-tetramethyl-7-oxaspiro[bicyclo[4.1.0]heptane-2,1'-cyclohexane]

C15H23Br2ClO (411.9804)

(3s,4s,9s)-4,9-dibromo-8-chloro-1,5,5,9-tetramethylspiro[5.5]undec-1-en-3-ol

C15H23Br2ClO (411.9804)

(1s,4r)-4,5'-dibromo-4'-chloro-1,3,3,4'-tetramethyl-7-oxaspiro[bicyclo[4.1.0]heptane-2,1'-cyclohexane]

C15H23Br2ClO (411.9804)

(2s,3r,6s,8r,9r)-2,8-dibromo-9-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecan-3-ol

C15H23Br2ClO (411.9804)

(1s,2r,3's,4r,4's,6r)-3',4-dibromo-4'-chloro-1,3,3,4'-tetramethyl-7-oxaspiro[bicyclo[4.1.0]heptane-2,1'-cyclohexane]

C15H23Br2ClO (411.9804)

methyl 13,15-dichloro-14-hydroxy-6-methoxy-4,12-dimethyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaene-5-carboxylate

C18H14Cl2O7 (412.0117)

(2s,3r,6s)-2,8-dibromo-9-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecan-3-ol

C15H23Br2ClO (411.9804)

(2r,3s)-2,8-dibromo-9-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecan-3-ol

C15H23Br2ClO (411.9804)

4,8-dibromo-9-chloro-5,5,9-trimethyl-1-methylidenespiro[5.5]undecan-2-ol

C15H23Br2ClO (411.9804)

4,5'-dibromo-4'-chloro-1,3,3,4'-tetramethyl-7-oxaspiro[bicyclo[4.1.0]heptane-2,1'-cyclohexane]

C15H23Br2ClO (411.9804)

methyl 13,15-dichloro-6,14-dihydroxy-4,7,12-trimethyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaene-5-carboxylate

C18H14Cl2O7 (412.0117)

3-bromo-5-(3-bromo-4-chloro-4-methylcyclohexyl)-2,2,6-trimethyl-3,4-dihydropyran

C15H23Br2ClO (411.9804)

(2s,3r,6r,8s,9s)-2,9-dibromo-8-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecan-3-ol

C15H23Br2ClO (411.9804)

(3s,4s,6s,8s,9s)-4,8-dibromo-9-chloro-1,5,5,9-tetramethylspiro[5.5]undec-1-en-3-ol

C15H23Br2ClO (411.9804)

(2s,3r,6s,8s,9s)-2,8-dibromo-9-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecan-3-ol

C15H23Br2ClO (411.9804)